Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2023 Oct 29;11(11):e8115.
doi: 10.1002/ccr3.8115. eCollection 2023 Nov.

Listeria monocytogenes bacteremia developed during treatment of COVID-19

Jin Yamamoto  1 , Keitaro Nakamoto  2 , Teppei Shimasaki  3 , Daisuke Kurai  3 , Takeshi Saraya  2 , Haruyuki Ishii  2
Affiliations
Case Reports

Listeria monocytogenes bacteremia developed during treatment of COVID-19

Jin Yamamoto et al. Clin Case Rep. .

Abstract

Listeria monocytogenes is an important pathogen in older patients and immunosuppressed patients, often causing bacteremia. Complications resulting from infections other than COVID-19 must also be considered during COVID-19 treatment.

Keywords: COVID‐19; Listeria monocytogenes; bacteremia.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest associated with this article.

Figures

FIGURE 1
FIGURE 1
Chest x‐ray showed faint infiltrates in the bilateral lungs (A). Chest computed tomography showed bilateral ground glass opacities or consolidations predominantly in the subpleural region (B, C).
FIGURE 2
FIGURE 2
Gram stain in blood culture showed Gram‐positive short bacilli that were isolated and identified as Listeria monocytogenes.
FIGURE 3
FIGURE 3
Clinical course in this case. CTRX, ceftriaxone; Dex, dexamethasone; RDV, remdesivir.
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Huang C, Lu TL, Yang Y. Mortality risk factors related to listeriosis—a meta‐analysis. J Infect Public Health. 2023;16(5):771‐783. - PubMed
    1. Charlier C, Perrodeau É, Leclercq A, et al. Clinical features and prognostic factors of listeriosis: the MONALISA national prospective cohort study. Lancet Infect Dis. 2017;17(5):510‐519. - PubMed
    1. Kikuchi T. COVID‐19 outbreak: an elusive enemy. Respir Investig. 2020;58(4):225‐226. - PMC - PubMed
    1. Terada M, Ohtsu H, Saito S, et al. Risk factors for severity on admission and the disease progression during hospitalisation in a large cohort of patients with COVID‐19 in Japan. BMJ Open. 2021;11(6):e047007. - PMC - PubMed
    1. Russell CD, Fairfield CJ, Drake TM, et al. Co‐infections, secondary infections, and antimicrobial use in patients hospitalised with COVID‐19 during the first pandemic wave from the ISARIC WHO CCP‐UK study: a multicentre, prospective cohort study. Lancet Microbe. 2021;2(8):e354‐e365. - PMC - PubMed

Publication types

LinkOut - more resources